Conversely, the expression of Bim was significantly lower in colon cancer than that in rectal cancer, in high-grade cancer than that in low-grade cancer, in late Dukes stage cancer than that in early Dukes stage cancer, and in deep invasive cancer than that in shallow invasive cancer. Here, BCL2L11 is linked to malignant colon neoplasm.